How DACH sellers of Non-Cyclical, Industrial, Life Science and Energy portfolios can minimise secondary market discounts and secure the best return.
DACH insurers are reviewing private equity holdings in healthcare, life sciences, pharma, agri and technology. The secondary market offers liquidity, portfolio repositioning and targeted private equity placements.
Secondary Market Opportunities for DACH Insurers Read Post »
Private equity secondaries in 2026 are being reshaped by tighter pricing, more sophisticated GP-led deals, and changing LP liquidity needs. We examine the key trends, valuation shifts, and what has changed for investors.
LP and GP Secondary Market Strategies in 2026: Trends, Pricing and What’s Changed Read Post »
From LP portfolio sales to GP-led continuation vehicles, this article breaks down how the private equity secondary market works in 2026 and what investors need to know.
Private Equity Secondary Market Explained: LP & GP Guide (2026) Read Post »
